Aqua Bio Technology ASA (ABT.OL)
NOK 6.93
(0.0%)
NOK 6.93
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2021 | -17.85 Million NOK | -10.88% |
| 2020 | -16.1 Million NOK | -22.71% |
| 2019 | -13.12 Million NOK | 28.54% |
| 2018 | -18.36 Million NOK | -23.44% |
| 2017 | -14.87 Million NOK | -620.18% |
| 2016 | 2.86 Million NOK | -81.46% |
| 2015 | 15.42 Million NOK | 2932.13% |
| 2014 | -544.58 Thousand NOK | -130.51% |
| 2013 | 1.78 Million NOK | -27.05% |
| 2012 | 2.44 Million NOK | 118.26% |
| 2011 | -13.39 Million NOK | 13.38% |
| 2010 | -15.46 Million NOK | -27.19% |
| 2009 | -12.16 Million NOK | 75.2% |
| 2008 | -49.04 Million NOK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2021 FY | -17.85 Million NOK | -10.88% |
| 2020 FY | -16.1 Million NOK | -22.71% |
| 2019 FY | -13.12 Million NOK | 28.54% |
| 2018 FY | -18.36 Million NOK | -23.44% |
| 2017 FY | -14.87 Million NOK | -620.18% |
| 2016 FY | 2.86 Million NOK | -81.46% |
| 2016 Q1 | 4.68 Million NOK | -12.44% |
| 2016 Q2 | -863.14 Thousand NOK | -118.42% |
| 2016 Q3 | -6.75 Million NOK | -683.0% |
| 2016 Q4 | 5.79 Million NOK | 185.75% |
| 2015 FY | 15.42 Million NOK | 2932.13% |
| 2015 Q3 | 3.35 Million NOK | 8.42% |
| 2015 Q4 | 5.35 Million NOK | 59.7% |
| 2015 Q1 | 3.62 Million NOK | 1062.85% |
| 2015 Q2 | 3.09 Million NOK | -14.8% |
| 2014 Q3 | 1.98 Million NOK | 211.16% |
| 2014 Q1 | -367.22 Thousand NOK | 85.38% |
| 2014 Q2 | -1.78 Million NOK | -386.67% |
| 2014 FY | -544.58 Thousand NOK | -130.51% |
| 2014 Q4 | -376.81 Thousand NOK | -118.97% |
| 2013 FY | 1.78 Million NOK | -27.05% |
| 2013 Q4 | -2.51 Million NOK | -759.76% |
| 2013 Q3 | 380.71 Thousand NOK | -71.97% |
| 2013 Q2 | 1.35 Million NOK | -46.89% |
| 2013 Q1 | 2.55 Million NOK | 284.27% |
| 2012 Q1 | 8.24 Million NOK | 273.87% |
| 2012 FY | 2.44 Million NOK | 118.26% |
| 2012 Q4 | -1.38 Million NOK | -307.99% |
| 2012 Q3 | -340.18 Thousand NOK | 91.64% |
| 2012 Q2 | -4.07 Million NOK | -149.37% |
| 2011 Q1 | -3.16 Million NOK | 31.42% |
| 2011 Q4 | -4.74 Million NOK | -144.83% |
| 2011 FY | -13.39 Million NOK | 13.38% |
| 2011 Q3 | -1.93 Million NOK | 45.42% |
| 2011 Q2 | -3.54 Million NOK | -11.97% |
| 2010 Q2 | -4.9 Million NOK | -53.21% |
| 2010 FY | -15.46 Million NOK | -27.19% |
| 2010 Q4 | -4.62 Million NOK | -50.34% |
| 2010 Q1 | -3.2 Million NOK | 0.0% |
| 2010 Q3 | -3.07 Million NOK | 37.3% |
| 2009 FY | -12.16 Million NOK | 75.2% |
| 2008 FY | -49.04 Million NOK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Arctic Bioscience AS | -48.58 Million NOK | 63.246% |
| ArcticZymes Technologies ASA | 15.74 Million NOK | 213.408% |
| BerGenBio ASA | -191.81 Million NOK | 90.691% |
| Hofseth BioCare ASA | -102.52 Million NOK | 82.583% |
| PCI Biotech Holding ASA | -22.24 Million NOK | 19.711% |
| Thor Medical ASA | -7.16 Million NOK | -149.401% |
| Ultimovacs ASA | -215.73 Million NOK | 91.723% |